LifeNet Health

What LifeNet Health does

LifeNet Health is a Virginia Beach-based nonprofit organization founded in 1982 that has operated in regenerative medicine for more than 40 years, processing and distributing human tissue allografts, facilitating organ procurement as an Organ Procurement Organization (OPO) in Virginia, and supplying research-grade human cells and tissues through its LifeSciences division. The company serves surgeons and healthcare facilities across nine clinical verticals — cardiac, vascular, sports medicine, orthopedics, trauma, craniomaxillofacial, spine, dental, and wound care — and reports more than 13 million allografts distributed since 1995 with no documented disease transmission. Its Virginia-headquartered operations span more than 1,500 employees globally, with additional production and laboratory sites in the Netherlands, North Charleston (South Carolina), and Kalamazoo (Michigan).

The company's competitive position rests on two proprietary technology platforms: Matracell decellularization (covered by U.S. Patent 6,743,574), which removes more than 99% of donor cells and DNA while preserving biomechanical strength, and Allowash sterilization, which has processed more than 13 million allografts with a 30-year clean safety record. Product franchises include ViviGen and OraGen viable bone allografts, the PliaFX family of advanced fiber demineralized bone matrices, Nexeon (the world's first room-temperature decellularized vascular graft), Matrion placental membrane for chronic wounds, CardioGraft-MC decellularized pulmonary patches, Dermacell Porous dermal matrix, and the TheraSkin wound-care line acquired from Bioventus. Recent acquisitions of HCM Medical (rebranded LifeNet Health Advanced Xeno-Therapeutics in 2026) and Tissue Testing Technologies (T3) extend the platform into xenografts and vitrification biopreservation, respectively. The regulatory stack — FDA registration, ISO 13485, CLIA, AATB (longest-running accreditation), and UNOS membership — creates a high barrier to entry.

LifeNet Health monetizes primarily through one-time sale of allograft biologics to hospitals and surgeons via a direct enterprise field-sales model, reinforced by a global channel-partner relationship with Johnson & Johnson MedTech for PliaFX Pak. Professional-services revenue streams come from its Virginia-based OPO, tissue donation services, and LifeSciences research contracts (priced at direct cost plus up to 20% overhead). Go-to-market combines dedicated Bio-Implant Specialists embedded with surgeons, 7am–7pm EST customer support with 24-hour on-call emergency coverage, conference presence at AAOS and NASS, and a Global Recovery Network Services (GRNS) partner network that secures donor tissue across regions.

Name

LifeNet Health

Legal name

LifeNet Health, Inc.

Website

https://lifenethealth.org

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

LifeNet Health is a 40-year-old nonprofit regenerative medicine organization that processes and distributes human tissue allografts across nine surgical categories, runs Virginia's organ procurement operations, and supplies research-grade human cells and tissues to surgeons, hospitals, and pharmaceutical researchers worldwide.

Ownership category

akta.pro rank

Product category

Regenerative Medicine & Tissue Banking

NAICS

Blood and Organ Banks (621991)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)

akta.pro secondary industries

Blood, Organ & Tissue Donation Organizations (BPAGACAJ), Organoids & Organ-on-Chip (regenerative models) (HLAAAGAD)

Keywords

• Allograft tissue products
• Regenerative medicine
• Organ procurement services
• Bio-implants manufacturing
• Cardiac tissue grafts

Headquarters

HQ city

Virginia Beach

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Allograft Bio-Implants Sales: LifeNet Health generates revenue through the sale of allograft biological implants including bone, tissue, cardiac, vascular, sports medicine, and wound care products to healthcare providers and hospitals.
2. Organ Procurement Organization Services: As an OPO, LifeNet Health facilitates organ donation and transplantation services, working with hospitals and transplant centers across Virginia.
3. LifeSciences Research Solutions: LifeNet Health LifeSciences provides human cell- and tissue-based research solutions to pharmaceutical and biotechnology companies, supporting drug discovery and development.
4. Contract Research Services: As a non-profit, LifeNet Health charges direct costs plus up to 20% overhead for research contract work with outside institutions. Services include non-clinical laboratory research and analytical services.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Core offering

LifeNet Health is a regenerative medicine organization that recovers, processes, and distributes human allograft bio-implants (bone, soft tissue, cardiac, vascular, sports medicine, and wound care grafts) for surgical use. It also operates as an Organ Procurement Organization (OPO) coordinating organ donation for transplantation, and provides research-grade biological materials to life sciences organizations.

Product overview

LifeNet Health is a global leader in regenerative medicine offering a comprehensive portfolio of allograft bio-implants and related services. The product portfolio includes bone allografts (ViviGen, OraGen, PliaFX family including PliaFX Pak, PliaFX Prime, PliaFX Strip, PliaFX Flo), vascular products (Nexeon), wound care solutions (Matrion, Dermacell Porous, TheraSkin, ArthroFlex), cardiac products (CardioGraft-MC), sports medicine constructs (FlexiGraft including QuadLink), and structural allografts (VertiGraft, SymAlign). The company also operates Organ Procurement Organization services, tissue donation services, and LifeSciences research solutions. Key technology platforms include Matracell decellularization technology and Allowash sterilization technology. Recent acquisitions include HCM Medical (now LifeNet Health Advanced Xeno-Therapeutics), Tissue Testing Technologies for biopreservation capabilities, and the wound care division of Bioventus Inc.

Differentiator

Problem solved

Functional benefit

Brands

• Nexeon: Advanced Vascular Allograft - the world's first decellularized, sterile, room temperature vascular allograft.
• Matrion
• LifeNet Health Advanced Xeno-Therapeutics (LifeNet Health AXT)
• LifeNet Health LifeSciences
• TheraSkin
• ViviGen
• PliaFX
• Dermacell
• OraGen
• CardioGraft-MC

Products and services

• Allograft Bio-Implants (Bone & Soft Tissue) Processed human bone and soft tissue allografts used by orthopedic surgeons, hospitals, and surgical centers for reconstructive procedures.
• Cardiac Allografts Human cardiac tissue grafts used by cardiac surgeons for valve replacement and cardiac repair procedures.
• Vascular Allografts Human vascular grafts for vascular surgeons performing bypass and reconstructive vascular procedures.
• Wound Care Allografts Skin and dermal allografts used by wound care specialists and burn centers for chronic wound and burn treatment.
• Organ Procurement & Donation Services Organ Procurement Organization (OPO) services coordinating the recovery and transplantation of organs from deceased donors to recipient hospitals.
• LifeSciences Research Products Research-grade biological materials and tissue samples supplied to academic institutions, biotech, and pharmaceutical companies for R&D.

Quantifiable outcome

• 13 million+ allografts processed with Allowash technology with zero disease transmission since 1995
• +6 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Ten partnerships are on record, tiered core, minor and strategic.

• NASA Langley Research CentercoreStrategic or Co-development Partner · 5 June 2026Collaboration on first-of-its-kind drone kidney transport study. NASA, UNOS, and LifeNet Health successfully completed groundbreaking drone flights transporting human kidneys beyond visual line of sight. Preliminary findings showed no evidence of damage to organs after biopsies and preservation pump assessments.
• United Network for Organ Sharing (UNOS)coreStrategic or Co-development Partner · 5 June 2026Partnership with NASA and LifeNet Health on drone kidney transport study to evaluate organ transportation technology. Goal is to improve reliability, reduce transit times, and expand access to transplantation for the 100,000+ people waiting for transplants in the U.S.
• Tissue Testing Technologies LLC (T3)coreStrategic or Co-development Partner · 15 December 2025Acquisition of biotech firm specializing in biopreservation. T3's technologies enable vitrification preservation and controlled warming for human and xenograft tissues, improving organ and tissue preservation for transplantation.
• HCM MedicalcoreStrategic or Co-development Partner · 20 August 2025Acquisition of Netherlands-based contract manufacturing organization to expand access to advanced health technologies and regenerative biologics. Brings closed-herd xenograft platform, antibiotic-coated implant technologies, and next-generation sterilization methods.
• Johnson & Johnson MedTechcoreChannel Partner/ Reseller/ Distributor · 1 August 2024Partnership for demineralized bone matrix products, including PliaFX Pak commercialized through J&J MedTech starting August 2024. Collaboration combines mineralized bone chips with demineralized fibers for orthopedic spine and trauma procedures.
• The Honor FoundationminorOthers · 24 May 2024Partnership with career transition program for U.S. Special Operations Forces to propel veteran careers into the civilian sector.
• Specialist DirectcoreTechnology or Integration · 1 January 2024Deployment of Mobile Telepathology for OPOs to improve organ recovery processes through field-based digital slide transmission for rapid pathology review. Since implementation, achieved 50% reduction in biopsy interpretation times and increased organ transplants by 84.
• Virginia Bioscience Foundation / GO VirginiaminorOthers · 1 January 2024Educational partnership with Landstown High School and Varina High School providing hands-on laboratory experiences for students to foster interest in life science careers.
• CN BiostrategicTechnology or Integration · 6 September 2023LifeNet Health LifeSciences partnership to supply and distribute hepatic cells to CN Bio, a leading organ-on-a-chip company that manufactures single- and multi-organ MPS platforms for drug discovery and safety testing.
• Bioventus Inc. (Wound Care Division)strategicStrategic or Co-development Partner · 10 May 2023Acquisition of wound care division including TheraSkin products to expand regenerative medicine portfolio and address medical needs of patients with chronic wounds. Acquisition added 90 employees.

Scale indicators9 records

Recent moves7 records

Expansion highlights8 records

Direct peers

• MTF Biologics: Non-profit musculoskeletal transplant foundation that processes and distributes allograft tissue for orthopedics, sports medicine, and wound care. Closest comparable operating model to LifeNet Health (nonprofit OPO-style tissue bank with broad allograft portfolio).
• AlloSource: Non-profit tissue bank specializing in allograft implants for spine, orthopedics, sports medicine, and wound care. Directly competes with LifeNet Health's biologics division across similar surgical specialties and customer segments.
• Bioventus: Public orthobiologics company whose wound care division was acquired by LifeNet Health in 2023. Direct peer in bone graft substitutes, hyaluronic acid, and chronic wound care biologics.
• Anika Therapeutics: Public regenerative medicine company focused on hyaluronic acid-based orthobiologics and surgical regenerative solutions. Comparable target markets in joint preservation, sports medicine, and regenerative soft-tissue repair.

Broad incumbents

• Arthrex: Large private orthopedics and sports medicine medtech with autologous biologics, graft preparation systems, and a deep salesforce in orthobiologics. Broad incumbent competing with LifeNet Health in sports medicine and orthopedic allograft/orthobiologic categories.
• Conmed: Public medical device company with orthopedic, sports medicine, and biologic product lines. Competes with LifeNet Health in sports medicine grafts and orthobiologics as part of a broader surgical portfolio.
• Integra LifeSciences: Public regenerative technology and neurosurgery company with regenerative tissue technologies (Durepair, DuraGen, Integra dermal matrices). Comparable in wound management, dermal matrices, and regenerative surgical implants.
• DePuy Synthes (Johnson & Johnson MedTech): Johnson & Johnson's orthopedics and spine business, which is both a channel partner (commercializing PliaFX Pak) and a broad competitive incumbent in spine, trauma, and orthobiologics. Directly relevant given its dual role as partner and competitor to LifeNet Health.
• Smith+Nephew: Global medical device company with orthopedics, sports medicine, and advanced wound management portfolios, including regenerative skin substitutes. Competes with LifeNet Health in wound care, sports medicine grafts, and orthopedic biologics.

Emerging players

• Vivex Biologics: Emerging orthobiologics player with cellular bone grafts, amniotic membranes, and spine allografts. Niche competitor in the same allograft/regenerative medicine categories where LifeNet Health's ViviGen and PliaFX compete.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/LifeNetHealth
• YouTubeyoutube.com/user/LNHealth
• Facebookfacebook.com/lnhfoundation
• LinkedInlinkedin.com/company/lifenet
• Instagraminstagram.com/lifenethealth

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeNet Health